Player Avatar DouglasRich (< 20) Submitted: 1/29/2008 9:30:45 AM : Underperform Start Price: $14.68 MYL Score: -233.59

Mylan is known for making good quality, reliable generic pharmaceutical products, but I think their primary drawback is they haven't found a way to outcompete the generic market. In the pharmacy, cheaper generics are preferred to Mylan's oftentimes more expensive products. Teva and Dr. Reddy are two companies, even though their tablets crumble to the touch, will always beat Mylan out of the inventory at CVS or Walgreens.

Member Avatar goldseth (< 20) Submitted: 3/19/2009 6:52:28 PM
Recs: 0

Look for a test of $12 support...the long term growth potential is priced in and Obama's national health care ambitions will bring regulatory and price control volatility along with the retail movement due to the new market cap/growth prospects. Be patient, don't chase!

Featured Broker Partners